Cardioprotective Potential of Mitochondria-targeted Antioxidant, Mito-TEMPO, in 5-fluorouracil-induced Cardiotoxicity

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 2023 Mar 30

PMID 36997656

Authors

Prasad Kisan Tambe

A Jesil Mathew

Sanjay Bharati

Affiliations

Soon will be listed here.

Abstract

Purpose: The mitochondria-targeted antioxidants (MTAs) are known to offer protection against mitochondrial oxidative stress. The recent evidences support their role in mitigating oxidative stress-induced diseases, including cancer. Therefore, this study investigated cardioprotective potential of mito-TEMPO against 5-FU-induced cardiotoxicity.

Methods: Mito-TEMPO was administered to male BALB/C mice (intraperitoneally, 0.1 mg/kg b.w. for 7 days) followed by intraperitoneal administration of 5- FU (12 mg/kg b.w. for 4 days). During this period, mito-TEMPO treatment was also continued. The cardioprotective potential of mito-TEMPO was assessed by evaluating cardiac injury markers, extent of non-viable myocardium and histopathological alterations. Mitochondrial functional status and mitochondrial oxidative stress were assessed in cardiac tissue. 8-OHdG expression and apoptotic cell death were assessed using immunohistochemical techniques.

Results: The level of cardiac injury markers CK-MB and AST were significantly (P ≤ 0.05) decreased in mito-TEMPO pre-protected group which was further reflected in histopathology as decrease in the percentage of non-viable myocardial tissue, disorganization, and loss of myofibrils. Mito-TEMPO ameliorated mtROS, mtLPO and conserved mitochondrial membrane potential. Further, it had significantly (P ≤ 0.05) improved the activity of mitochondrial complexes and mitochondrial enzymes. A significant (P ≤ 0.05) increase in the level of mtGSH, activity of mitochondrial glutathione reductase, glutathione peroxidase, and mitochondrial superoxide dismutase was observed. A decreased expression of 8-OHdG and reduced apoptotic cell death were observed in mito-TEMPO pre-protected group.

Conclusion: Mito-TEMPO effectively mitigated 5-FU-induced cardiotoxicity by modulating mitochondrial oxidative stress, hence may serve as a protective agent/adjuvant in 5-FU-based combinatorial chemotherapy.

Citing Articles

The association between systemic immune-inflammation index and cardiotoxicity related to 5-Fluorouracil in colorectal cancer.

Liu X, Wang Y, Wang W, Dong H, Wang G, Chen W BMC Cancer. 2024; 24(1):782.

PMID: 38951749 PMC: 11218411. DOI: 10.1186/s12885-024-12568-0.

ATF5-regulated Mitochondrial Unfolded Protein Response Attenuates Neuronal Damage in Epileptic Rat by Reducing Endoplasmic Reticulum Stress Through Mitochondrial ROS.

Lian X, Wang X, Xie Y, Sheng H, He J, Peng T Neurochem Res. 2023; 49(2):388-401.

PMID: 37847329 DOI: 10.1007/s11064-023-04042-3.

References

Kang Y . Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect. 2001; 109 Suppl 1:27-34. PMC: 1240540. DOI: 10.1289/ehp.01109s127. View

Borshchev Y, Minasian S, Burovenko I, Borshchev V, Protsak E, Semenova N . Effects of tetracycline on myocardial infarct size in obese rats with chemically-induced colitis. PLoS One. 2019; 14(11):e0225185. PMC: 6850547. DOI: 10.1371/journal.pone.0225185. View

El-Beshbishy H, Aly H, El-Shafey M . Lipoic acid mitigates bisphenol A-induced testicular mitochondrial toxicity in rats. Toxicol Ind Health. 2012; 29(10):875-87. DOI: 10.1177/0748233712446728. View

Al Kaddissi S, Legeay A, Elia A, Gonzalez P, Floriani M, Cavalie I . Mitochondrial gene expression, antioxidant responses, and histopathology after cadmium exposure. Environ Toxicol. 2012; 29(8):893-907. DOI: 10.1002/tox.21817. View

Pecoraro M, Del Pizzo M, Marzocco S, Sorrentino R, Ciccarelli M, Iaccarino G . Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity. Toxicol Appl Pharmacol. 2016; 293:44-52. DOI: 10.1016/j.taap.2016.01.006. View

Yuan Y, Ma Z, Zhang X, Xu S, Zeng X, Yang Z . CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1. J Mol Cell Cardiol. 2017; 114:38-47. DOI: 10.1016/j.yjmcc.2017.10.008. View

Qsee H, Tambe P, De S, Bharati S . MitoQ demonstrates connexin- and p53-mediated cancer chemoprevention in N-nitrosodiethylamine-induced hepatocarcinogenesis rodent model. Toxicol Appl Pharmacol. 2022; 453:116211. DOI: 10.1016/j.taap.2022.116211. View

Khurana R, Jain A, Jain A, Sharma T, Singh B, Kesharwani P . Administration of antioxidants in cancer: debate of the decade. Drug Discov Today. 2018; 23(4):763-770. DOI: 10.1016/j.drudis.2018.01.021. View

Kanduri J, More L, Godishala A, Asnani A . Fluoropyrimidine-Associated Cardiotoxicity. Cardiol Clin. 2019; 37(4):399-405. DOI: 10.1016/j.ccl.2019.07.004. View

10.

Bi W, Bi Y, Li P, Hou S, Yan X, Hensley C . Indole Alkaloid Derivative B, a Novel Bifunctional Agent That Mitigates 5-Fluorouracil-Induced Cardiotoxicity. ACS Omega. 2018; 3(11):15850-15864. PMC: 6275955. DOI: 10.1021/acsomega.8b02139. View

11.

Shetty S, Anushree U, Kumar R, Bharati S . Mitochondria-targeted antioxidant, mito-TEMPO mitigates initiation phase of N-Nitrosodiethylamine-induced hepatocarcinogenesis. Mitochondrion. 2021; 58:123-130. DOI: 10.1016/j.mito.2021.03.001. View

12.

McFarland V, Inouye L, Lutz C, Jarvis A, Clarke J, McCant D . Biomarkers of oxidative stress and genotoxicity in livers of field-collected brown bullhead, Ameiurus nebulosus. Arch Environ Contam Toxicol. 1999; 37(2):236-41. DOI: 10.1007/s002449900510. View

13.

Eskandari M, Moghaddam F, Shahraki J, Pourahmad J . A comparison of cardiomyocyte cytotoxic mechanisms for 5-fluorouracil and its pro-drug capecitabine. Xenobiotica. 2014; 45(1):79-87. DOI: 10.3109/00498254.2014.942809. View

14.

Rocha V, de Aragao Franca L, Araujo C, Ng A, de Andrade C, Andrade A . Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice. Cancer Chemother Pharmacol. 2015; 77(3):659-62. DOI: 10.1007/s00280-015-2949-7. View

15.

Banerjee P, Saha I, Sarkar D, Maiti A . Contributions and Limitations of Mitochondria-Targeted and Non-Targeted Antioxidants in the Treatment of Parkinsonism: an Updated Review. Neurotox Res. 2022; 40(3):847-873. DOI: 10.1007/s12640-022-00501-x. View

16.

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

17.

Mercuro G, Cadeddu C, Piras A, Dessi M, Madeddu C, Deidda M . Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers. Oncologist. 2007; 12(9):1124-33. DOI: 10.1634/theoncologist.12-9-1124. View

18.

Krainz T, Gaschler M, Lim C, Sacher J, Stockwell B, Wipf P . A Mitochondrial-Targeted Nitroxide Is a Potent Inhibitor of Ferroptosis. ACS Cent Sci. 2016; 2(9):653-659. PMC: 5043442. DOI: 10.1021/acscentsci.6b00199. View

19.

Refaie M, Abdel-Gaber S, Rahman S, Abdel Hafez S, Khalaf H . Cardioprotective effects of bosentan in 5-fluorouracil-induced cardiotoxicity. Toxicology. 2021; 465:153042. DOI: 10.1016/j.tox.2021.153042. View

20.

Ellman G . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7. DOI: 10.1016/0003-9861(59)90090-6. View